IL18 and pulmonary emphysema: We previously reported that in vivo overexpression of IL-18 alone is not sufficient to elicit lung disease, since lymphocyte-specific IL-18 B6 Tg mice [9], and skin-specific IL-18 B6 Tg mice [10] did not exhibit pulmonary inflammation or emphysema.